Get startedLog in
    Picture of Trinity Biotech logo

    TRIB — Trinity Biotech News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    All News

    Trinity Biotech PLC reports results for the quarter ended December 31 - Earnings Summary

    Picture of Trinity Biotech logoTrinity Biotech
    15/05/2025 22:05
    Trinity Biotech PLC TRIB.OQ reported a quarterly adjusted loss of $1.14​​ per share for the quarter ended December 31.  The lone analyst forecast for the quarter was for a loss of 30 cents per share.

Revenue rose 18.1% to $15.86 million from a year ago; analysts expected $16.50 million.

Trinity Biotech PLC's reported EPS for the quarter was a loss of $1.28​.

The company reported a quarterly loss of $16.96 million.

Trinity Biotech PLC shares had risen by 40.4% this quarter and lost 9.1% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

This summary was machine generated from LSEG data May 15 at 09:04 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)


    QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
    Dec. 31 2024-0.30-1.14Missed
    Sep. 30 2024-0.54-0.46Beat
    Jun. 30 2024-0.65-0.71Missed

    Recent news on Trinity Biotech

    See all news